While awaiting the availability of next-generation influenza vaccines, clinicians have the task of convincing patients of the value of influenza immunization in a season with
Coadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and seasonal influenza vaccine (SIV) in the community setting produced similar effectiveness and outcomes as when
Among 3,692 participants in the Chronic Renal Insufficiency Cohort Study (CRIC), factors associated with not receiving influenza vaccination were younger adults, Black individuals, and adverse
In 3 articles, the American Academy of Pediatrics summarizes recommendations of the Advisory Committee on Immunization Practices (ACIP) for the use of vaccines for the
Among older adults, receipt of high-dose (HD) influenza vaccine was associated with lower post-influenza mortality compared with standard-dose (SD) products or no vaccination, a study
The risk of hospitalization for ambulatory patients with influenza was not affected by treatment with oseltamivir, according to a systematic review and meta-analysis, but gastrointestinal
Hospitalized individuals in a VA population during the fall and winter of 2022 and 2023 had higher mortality rates with COVID-19 than with influenza, researchers
In the 9 influenza seasons after the 2009 A(H1N1) pandemic, vaccinations provided “substantial benefit against outpatient illness,” according to a CDC study, with vaccine effectiveness
The 2022–23 influenza vaccine has provided reasonable protection against infection and hospitalization caused by infection, members of the CDC’s Advisory Committee on Immunization Practices heard
FDA yesterday approved etranacogene dezaparvovec (Hemgenix, CSL Behring), an adeno-associated virus vector-based gene therapy for the treatment of adults with hemophilia B (congenital factor IX